The global big pharma company Bayer has decided to move its Swedish operations to the Karolinska Institute Campus in Solna and it has also entered collaborations with Norrsken Foundation.
According to Maria Rankka, CEO of the Swedish Chamber of Commerce, the move to the Karolinska Institute Campus is important for both Stockholm and Sweden.
“Stockholm can become a world leading hub within both life science and health tech. The vision is to create a knowledge cluster for research, healthcare and large and small companies. If we succeed, the whole region’s attractiveness will increase. In this context, the Bayer move is an important key,” she says.
According to Henrik Wulff, CEO of Bayer Sweden, the move to the KI Campus is a natural step and it reflects the company’s entire approach.
“We know that innovation at its best is when different perspectives meet and this move symbolize our faith to the power of collaboration. We are convinced that this move will result in exciting, innovative encounters which will have positive effects on both humans and the society as a whole,” he says.
Bayer has also entered a collaboration agreement with Norrsken Foundation to solve global challenges related to health and nutrition. The partnership involves collaboration locally in Sweden as well as globally, including a potential expansion of Norrsken’s global presence to support social impact entrepreneurs.
“The collaboration with Norrsken opens up a great opportunity to bring the amazing individuals on both sides together to share ideas and potentially create new businesses together” says Dr. Axel Bouchon, Head of Leaps by Bayer.
“When we met with Leaps by Bayer for the first time, we immediately saw the significant overlap in values and ambition level between Norrsken and Leaps. Therefore we believe there is tremendous opportunity for us and all the Norrsken companies with this partnership. True to their vision, Leaps is taking a big bet on Norrsken to help enable an impact unicorn, a company positively affecting one billion people”, says Erik Engellau-Nilsson, the CEO of Norrsken Foundation.
Bayer and Norrsken will jointly strive for Norrsken House entrepreneurs and Bayer employees to collaborate and develop new business models and ideas. Norrsken and Bayer will work together on events and Mashup seminars hosted at Norrsken House throughout the year.
Norrsken is Swedish non-profit organization founded in 2016 with the purpose of solving some of the world’s most pressing challenges. The Foundation runs the co-working hub Norrsken House, an impact VC fund of €30M and two in-house initiatives, Klarity & 29k. The Foundation has secured €200M in funding from the co-founder of the Swedish fin-tech unicorn Klarna.
Photo of Henrik Wulff, CEO, Bayer Sweden